718 results on '"Labenz, J."'
Search Results
2. Gastroösophageale Refluxkrankheit – Update 2021
3. Burnout and work satisfaction in general practitioners practicing in rural areas: results from the HaMEdSi study
4. EndoStim®-Therapie – eine neue minimal-invasive Technologie in der Antirefluxchirurgie
5. Ein Virtual-Reality-Fahrtest zur Vorhersage von Autounfällen bei Patienten mit Leberzirrhose
6. Die minimale hepatische Enzephalopathie ist mit einem höheren Risiko für eine overte hepatische Enzephalopathie und schlechterer Prognose assoziiert
7. Burnout and work satisfaction in general practitioners practicing in rural areas: results from the HaMEdSi study [Corrigendum]
8. Outcomes of different treatment opproaches for gastro-oesophageal reflux disease
9. Gastroenterologische Erkrankungen als Auslöser von Thoraxschmerz
10. Barrett-Ösophagus
11. Prävalenz und natürlicher Verlauf der gastroösophagealen Refluxkrankheit
12. Application of a multispecies probiotic reduces gastro-intestinal discomfort and induces microbial changes after colonoscopy
13. Helicobacter pylori eradication leads to gastro-oesophageal reflux disease
14. Direkt wirkende orale Antikoagulanzien bei gastrointestinaler Blutung: Interventionelles Therapiemanagement
15. Submucosal Fibrin Adhesion in Upper Gastrointestinal Bleeding
16. Submucosal Fibrin Adhesion in Upper Gastrointestinal Bleeding
17. Divertikelblutung: Diagnostik, konservative Therapie, Operationsindikation
18. Ciprofloxacin-Omeprazole Treatment for Eradication of Helicobacter pylori
19. Amoxicillin—Omeprazole Treatment for Eradication of Helicobacter pylori
20. Facts and fantasies in extra-oesophageal symptoms in GORD
21. Management of reflux esophagitis: does the choice of proton pump inhibitor matter?
22. Die Gastroenterologie in der ersten und zweiten Corona-Welle - zwei Umfragen der Arbeitsgemeinschaft Leitender Gastroenterologischer Krankenhausärzte (ALGK)
23. Der Fokus liegt auf der individuellen Risikobewertung: Schmerztherapie mit NSAR
24. Das ABC der medizinischen Statistik – Klinische Studien lesen und verstehen
25. Das ABC der medizinischen Statistik: Klinische Studien lesen und verstehen
26. Prospective multicentre study on antimicrobial resistance of Helicobacter pylori in Germany
27. Therapieresistente Refluxkrankheit: Wie und wie lange medikamentös therapieren? Wann operieren?
28. Diagnostik der Helicobacter-pylori-Infektion: Wer die Wahl hat, hat die Qual
29. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the proGORD study
30. Pathophysiologie und Diagnostik der Refluxkrankheit
31. Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease: A prospective follow-up analysis based on the ProGERD study
32. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial. (Stomach)
33. Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care – the ProGERD study
34. UEGW-Update: Wichtige neue Erkenntnisse im Überblick
35. Intragastric acidity during administration of generic omeprazole or esomeprazole – a randomised, two-way crossover study including CYP2C19 genotyping
36. Angst vor PPI-Nebenwirkungen und Verordnungsverhalten der Ärzte
37. A false sense of security; symptom control does not predict healing of oesophagitis on proton pump inhibitors: Authorʼs reply
38. Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis - results from the maintenance phase of the EXPO study
39. Clinical course of laryngo-respiratory symptoms in gastro-oesophageal reflux disease during routine care - a 5-year follow-up
40. Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis – results from the EXPO study
41. Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study
42. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case–control study
43. Tai Chi hilft Patienten mit Kniegelenksarthrose
44. Long-term treatment of patients with gastro-oesophageal reflux disease in routine care – results from the ProGERD study
45. Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrettʼs mucosa
46. Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagus
47. Lifestyle factors and symptoms of gastro-oesophageal reflux – a population-based study
48. Esomeprazole: potent acid suppression in the treatment of acid-related disorders
49. Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study1
50. Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily – a randomized, two-way crossover study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.